BioPharmGuy logo
Sponsored By:
Sponsorship Available
Purchase the BioPharmGuy data
Sinclair Research
SOFAR surgical is defunct.

Fate: Acquired by TransEnterix, Sept 2015, $100M


------------------
If you believe any of this information is incorrect, please let us know.